Yanwen Fu

496 total citations
21 papers, 357 citations indexed

About

Yanwen Fu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yanwen Fu has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yanwen Fu's work include Chemical Synthesis and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Protein Structure and Dynamics (4 papers). Yanwen Fu is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Protein Structure and Dynamics (4 papers). Yanwen Fu collaborates with scholars based in United States, China and Netherlands. Yanwen Fu's co-authors include Robert P. Hammer, Jan Bieschke, Jeffery W. Kelly, Robin L. McCarley, Jianmin Gao, Mark L. McLaughlin, Frank R. Fronczek, Lars G.J. Hammarström, Caishun Zhang and Jing Dong and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Cancer Research.

In The Last Decade

Yanwen Fu

21 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanwen Fu United States 11 201 124 112 43 43 21 357
Kevin J. Robbins United States 8 248 1.2× 163 1.3× 101 0.9× 34 0.8× 50 1.2× 11 372
Anna Wahlström Sweden 7 251 1.2× 256 2.1× 28 0.3× 48 1.1× 92 2.1× 8 414
Kishore Thalluri India 10 199 1.0× 43 0.3× 196 1.8× 14 0.3× 32 0.7× 15 301
Martin D. Jeppesen Denmark 9 297 1.5× 167 1.3× 24 0.2× 46 1.1× 103 2.4× 9 455
Andrew J. Kassick United States 11 160 0.8× 29 0.2× 224 2.0× 35 0.8× 25 0.6× 20 434
Kyonghee Kim United States 10 303 1.5× 33 0.3× 171 1.5× 61 1.4× 16 0.4× 13 417
Srinivas K. Battina United States 10 137 0.7× 65 0.5× 130 1.2× 10 0.2× 16 0.4× 12 327
Whei‐Mei Wu United States 13 148 0.7× 22 0.2× 41 0.4× 41 1.0× 23 0.5× 20 398
George Pairas Greece 11 227 1.1× 21 0.2× 294 2.6× 43 1.0× 13 0.3× 42 516
Kinshuk Raj Srivastava India 12 202 1.0× 69 0.6× 34 0.3× 23 0.5× 33 0.8× 29 319

Countries citing papers authored by Yanwen Fu

Since Specialization
Citations

This map shows the geographic impact of Yanwen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwen Fu more than expected).

Fields of papers citing papers by Yanwen Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanwen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwen Fu. The network helps show where Yanwen Fu may publish in the future.

Co-authorship network of co-authors of Yanwen Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanwen Fu. A scholar is included among the top collaborators of Yanwen Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwen Fu. Yanwen Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Yanwen, Yixin Liu, Mingxuan Cui, et al.. (2023). The role of inflammatory biomarkers in the development and progression of pre-eclampsia: a systematic review and meta-analysis. Frontiers in Immunology. 14. 1156039–1156039. 17 indexed citations
2.
Adelsberg, Daniel C., Shreyas Kowdle, Christian S. Stevens, et al.. (2023). An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody. mBio. 15(1). e0247723–e0247723. 2 indexed citations
3.
Lim, Reyna K. V., Matthew D. Buschman, Alisher Khasanov, et al.. (2023). Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET. Expert Opinion on Biological Therapy. 23(11). 1137–1149. 1 indexed citations
4.
Zhang, Qing, Caishun Zhang, Haidan Wang, et al.. (2022). Intermittent Fasting versus Continuous Calorie Restriction: Which Is Better for Weight Loss?. Nutrients. 14(9). 1781–1781. 30 indexed citations
5.
Fu, Yanwen, et al.. (2020). Protective Effect of Recombinant Proteins of Cronobacter Sakazakii During Pregnancy on the Offspring. Frontiers in Cellular and Infection Microbiology. 10. 15–15. 4 indexed citations
6.
Zhou, Zhenzhen, Qian Liu, Yanwen Fu, et al.. (2020). Multi-channel fiber optical spectrometer for high-throughput characterization of photoluminescence properties. Review of Scientific Instruments. 91(12). 123113–123113. 5 indexed citations
7.
Patterson, James T, et al.. (2017). Chemically generated IgG2 bispecific antibodies through disulfide bridging. Bioorganic & Medicinal Chemistry Letters. 27(16). 3647–3652. 14 indexed citations
8.
Patterson, James T, Jason Isaacson, Rohit Duggal, et al.. (2017). PSMA-targeted bispecific Fab conjugates that engage T cells. Bioorganic & Medicinal Chemistry Letters. 27(24). 5490–5495. 13 indexed citations
9.
Li, Lingna, Edwige Gros, Yanliang Zhang, et al.. (2016). Abstract 3897: A novel c-Met targeting antibody drug conjugate for NSCLC. Cancer Research. 76(14_Supplement). 3897–3897. 1 indexed citations
10.
Chen, Gang, Lingna Li, Edwige Gros, et al.. (2015). Abstract LB-002: A novel c-Met/EGFR bispecific targeting antibody drug conjugate for NSCLC. Cancer Research. 75(15_Supplement). LB–2. 1 indexed citations
11.
Fu, Yanwen, Edwige Gros, Alice A. Lee, et al.. (2015). Abstract P2-16-03: C-Met is a potential therapeutic target for antibody-drug conjugates in breast cancer. Cancer Research. 75(9_Supplement). P2–16. 1 indexed citations
12.
Wang, Jia, Dan McElheny, Yanwen Fu, et al.. (2009). A 310‐helical pentapeptide in water: Interplay of α,α‐disubstituted amino acids and the central residue on structure formation. Biopolymers. 92(5). 452–464. 4 indexed citations
14.
Fu, Yanwen, et al.. (2006). Stoichiometric Inhibition of Amyloid β-Protein Aggregation with Peptides Containing Alternating α,α-Disubstituted Amino Acids. Journal of the American Chemical Society. 128(11). 3522–3523. 75 indexed citations
15.
Fu, Yanwen, et al.. (2006). Amide-to-E-Olefin versus Amide-to-Ester Backbone H-Bond Perturbations:  Evaluating the O−O Repulsion for Extracting H-Bond Energies. Journal of the American Chemical Society. 128(50). 15948–15949. 35 indexed citations
16.
Fu, Yanwen, Jan Bieschke, & Jeffery W. Kelly. (2005). E-Olefin Dipeptide Isostere Incorporation into a Polypeptide Backbone Enables Hydrogen Bond Perturbation:  Probing the Requirements for Alzheimer's Amyloidogenesis. Journal of the American Chemical Society. 127(44). 15366–15367. 42 indexed citations
17.
Fu, Yanwen, et al.. (2003). Facile Synthesis of α,α-Diisobutylglycine and Anchoring Its Derivatives onto PAL-PEG-PS Resin. The Journal of Organic Chemistry. 68(25). 9854–9857. 12 indexed citations
18.
Fu, Yanwen & Robert P. Hammer. (2001). Efficient Acylation of theN-Terminus of Highly HinderedCα,α-Disubstituted Amino Acids via Amino Acid Symmetrical Anhydrides. Organic Letters. 4(2). 237–240. 18 indexed citations
19.
Fu, Yanwen, et al.. (2001). Sterically HinderedCα,α-Disubstituted α-Amino Acids:  Synthesis from α-Nitroacetate and Incorporation into Peptides. The Journal of Organic Chemistry. 66(21). 7118–7124. 37 indexed citations
20.
Fu, Yanwen, Huaiwen Yang, Wumin Dai, et al.. (1999). A monohelical cobalt(II) complex of a quinquepyridine ligand. Acta Crystallographica Section C Crystal Structure Communications. 55(3). 349–351. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026